Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance
Emma L. Robinson, Rushita A. Bagchi, Jennifer L. Major, Bryan C. Bergman, Jennifer L. Matsuda, Timothy A. McKinsey
Emma L. Robinson, Rushita A. Bagchi, Jennifer L. Major, Bryan C. Bergman, Jennifer L. Matsuda, Timothy A. McKinsey
View: Text | PDF
Research Article Metabolism

HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance

  • Text
  • PDF
Abstract

Stimulation of adipocyte β-adrenergic receptors (β-ARs) induces expression of uncoupling protein 1 (UCP1), promoting nonshivering thermogenesis. Association of β-ARs with a lysine-myristoylated form of A kinase–anchoring protein 12 (AKAP12, also known as gravin-α) is required for downstream signaling that culminates in UCP1 induction. Conversely, demyristoylation of gravin-α by histone deacetylase 11 (HDAC11) suppresses this pathway. Whether inhibition of HDAC11 in adipocytes is sufficient to drive UCP1 expression independently of β-ARs is not known. Here, we demonstrate that adipocyte-specific deletion of HDAC11 in mice leads to robust induction of UCP1 in adipose tissue (AT), resulting in increased body temperature. These effects are mimicked by treating mice in vivo or human AT ex vivo with an HDAC11-selective inhibitor, FT895. FT895 triggers biphasic, gravin-α myristoylation–dependent induction of UCP1 protein expression, with a noncanonical acute response that is posttranscriptional and independent of protein kinase A (PKA), and a delayed response requiring PKA activity and new Ucp1 mRNA synthesis. Remarkably, HDAC11 inhibition promotes UCP1 expression even in models of adipocyte catecholamine resistance where β-AR signaling is blocked. These findings define cell-autonomous, multimodal roles for HDAC11 as a suppressor of thermogenesis, and highlight the potential of inhibiting HDAC11 to therapeutically alter AT phenotype independently of β-AR stimulation.

Authors

Emma L. Robinson, Rushita A. Bagchi, Jennifer L. Major, Bryan C. Bergman, Jennifer L. Matsuda, Timothy A. McKinsey

×

Figure 1

Adipocyte-specific knockout of HDAC11 in mice is sufficient to induce UCP1 protein expression and promote thermogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Adipocyte-specific knockout of HDAC11 in mice is sufficient to induce UC...
(A) Schematic representation of the Hdac11-floxed allele (Hdac11fl), with loxP sites flanking the 162 base pair (bp) exon 2; the predicted size of the resulting PCR product generated from genomic DNA and forward (F) and reverse (R) primers is shown. (B) Schematic representation of the cross between adiponectin promoter–driven Cre recombinase (Adipoq-Cre) transgenic mice and Hdac11fl/fl mice and the genomic DNA PCR approach to assessing excision of Hdac11 exon 2. (C) Genomic DNA PCR products from Hdac11fl/fl mice without (–) and with (+) the Adipoq-Cre transgene. (D) Diagram describing the genotype and definition of the adipocyte-specific conditional Hdac11-KO (Hd11cKO) and control Hd11fl/fl mice. (E) Immunoblot analysis of HDAC11 and UCP1 protein in epididymal white adipose tissue (eWAT), inguinal white adipose tissue (ingWAT), and interscapular brown adipose tissue (BAT) from 10- to 12-week-old control and Hdac11cKO mice. GAPDH served as a loading control; n = 3 biological replicates/group. (F and G) Densitometric analysis of HDAC11 and UCP1 protein in E, normalized to GAPDH and plotted relative to controls. Data are depicted as mean + SEM, with *P < 0.05 as determined by 2-tailed, unpaired t test. (H) Schematic representation of the cell culture experiment with recombinant Cre recombinase (recCre). (I) Immunoblot analysis of HDAC11 and UCP1 protein in preadipocytes. (J) Schematic representation of the 24-hour 4°C challenge experiment. (K) Core body temperature over time. Data are depicted as mean ± SEM, with *P < 0.05 vs. control mice at a given time as determined by 2-way ANOVA with Šidák’s multiple-comparison test; n = 7 biological replicates/group. (L) Adipose tissue weight, normalized to tibia length, determined after the 24-hour 4°C challenge. Data are depicted as mean + SEM, with *P < 0.05 as determined by 2-tailed, unpaired t test. (M) Immunohistochemistry of UCP1 protein in eWAT from mice sacrificed following the 24-hour 4°C challenge. Scale bars: 200 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts